HOUSTON--(BUSINESS WIRE)--PLx Pharma is pleased to announce that Professor Barry J. Marshall, co-recipient of the 2005 Nobel Prize in Physiology and Medicine for the elucidation of the role of Helicobacter pylori in gastric ulcerogenesis, and recipient of many internationally distinguished awards including the Albert Lasker Award, has agreed to serve on its Scientific Advisory Board. “I am intrigued by the promise of a G-I safer NSAID which has been demonstrated by PLx’s NSAID-PC technology in at risk osteoarthritis patients and look forward to assisting them as they continue with the development of additional NSAID-PC products such as Naproxen-PC and Aspirin-PC,” said Professor Marshall. “PLx’s pipeline of NSAID-PC products has the potential to provide GI safer alternatives to products now being taken by millions of patients.”
